DK1341899T3 - Bakterieværtsstammer - Google Patents
BakterieværtsstammerInfo
- Publication number
- DK1341899T3 DK1341899T3 DK01987349T DK01987349T DK1341899T3 DK 1341899 T3 DK1341899 T3 DK 1341899T3 DK 01987349 T DK01987349 T DK 01987349T DK 01987349 T DK01987349 T DK 01987349T DK 1341899 T3 DK1341899 T3 DK 1341899T3
- Authority
- DK
- Denmark
- Prior art keywords
- prc
- strain
- bacterial host
- host strains
- degp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25616200P | 2000-12-14 | 2000-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1341899T3 true DK1341899T3 (da) | 2006-04-10 |
Family
ID=22971286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01987349T DK1341899T3 (da) | 2000-12-14 | 2001-12-07 | Bakterieværtsstammer |
Country Status (23)
Country | Link |
---|---|
US (1) | US6828121B2 (da) |
EP (1) | EP1341899B9 (da) |
JP (1) | JP4056880B2 (da) |
KR (1) | KR100841486B1 (da) |
CN (1) | CN1233820C (da) |
AT (1) | ATE318890T1 (da) |
AU (2) | AU3957602A (da) |
BR (1) | BR0116680A (da) |
CA (1) | CA2430249A1 (da) |
CZ (1) | CZ304484B6 (da) |
DE (1) | DE60117601T2 (da) |
DK (1) | DK1341899T3 (da) |
ES (1) | ES2259338T3 (da) |
HK (1) | HK1058686A1 (da) |
HU (1) | HU230065B1 (da) |
IL (2) | IL156111A0 (da) |
MX (1) | MXPA03005271A (da) |
NO (1) | NO328987B1 (da) |
NZ (1) | NZ526134A (da) |
PL (1) | PL205897B1 (da) |
RU (1) | RU2287574C2 (da) |
WO (1) | WO2002048376A2 (da) |
ZA (1) | ZA200304101B (da) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6979556B2 (en) * | 2000-12-14 | 2005-12-27 | Genentech, Inc. | Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes |
WO2003018771A2 (en) | 2001-08-27 | 2003-03-06 | Genentech, Inc. | A system for antibody expression and assembly |
JP4050559B2 (ja) * | 2002-06-28 | 2008-02-20 | 富士通株式会社 | コンテンツ検索処理プログラム、コンテンツ検索処理プログラムを記録した記録媒体およびオペレータ問合せ処理システム |
US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
NZ568403A (en) * | 2003-05-09 | 2009-10-30 | Univ Duke | CD20-specific antibodies and methods of employing same |
AU2004282984B2 (en) | 2003-11-13 | 2011-07-14 | Hanmi Science Co., Ltd. | Protein complex using immunoglobulin fragment andmethod for the preparation thereof |
US8110665B2 (en) | 2003-11-13 | 2012-02-07 | Hanmi Holdings Co., Ltd. | Pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
US8227241B2 (en) * | 2004-03-12 | 2012-07-24 | Unigene Laboratories, Inc. | Bacterial host cell for the direct expression of peptides |
EP2412816B1 (en) | 2004-07-26 | 2014-12-03 | Pfenex Inc. | Process for improved protein expression by strain engineering |
AU2006249305B2 (en) | 2005-05-26 | 2012-10-18 | Genentech, Inc. | Humanized anti-CD40 antibodies and their methods of use |
US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
EP2142651B1 (en) | 2007-04-27 | 2013-05-22 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
EP2176291A1 (en) * | 2007-08-10 | 2010-04-21 | Wacker Chemie AG | Expression of full length igg and secretion into the culture medium of prokaryotic cells |
PE20120622A1 (es) | 2009-06-17 | 2012-05-26 | Abbott Biotherapeutics Corp | Anticuerpos anti-vegf y sus usos |
KR101758942B1 (ko) * | 2009-09-24 | 2017-07-17 | 유씨비 파마, 에스.에이. | 박테리아 숙주 균주 |
WO2011036455A1 (en) | 2009-09-24 | 2011-03-31 | Ucb Pharma S.A. | Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes |
US8361744B2 (en) | 2009-11-05 | 2013-01-29 | Genentech, Inc. | Methods and composition for secretion of heterologous polypeptides |
GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201000590D0 (en) * | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
EP3339325A1 (en) * | 2011-07-13 | 2018-06-27 | UCB Biopharma SPRL | Bacterial host strain expressing recombinant dsbc |
GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
WO2014003709A1 (en) * | 2012-06-25 | 2014-01-03 | Empire Technology Development Llc | Ultrasound based antigen binding detection |
MX2015003028A (es) | 2012-09-17 | 2015-06-10 | Hoffmann La Roche | Metodo para produccion de polipeptidos en periplasma de celulas procarioticas. |
US20140154255A1 (en) | 2012-11-30 | 2014-06-05 | Abbvie Biotherapeutics Inc. | Anti-vegf antibodies and their uses |
ES2897765T3 (es) | 2014-03-14 | 2022-03-02 | Hoffmann La Roche | Procedimientos y composiciones para la secreción de polipéptidos heterólogos |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
JP7033795B2 (ja) * | 2017-02-22 | 2022-03-11 | 国立大学法人 長崎大学 | 生体由来材料の透明化用試薬 |
CN106967658B (zh) * | 2017-02-23 | 2020-09-15 | 郑州大学 | 一种提高Fab抗体表达量的方法 |
CN108587992B (zh) * | 2018-04-10 | 2022-03-15 | 安徽大学 | 一种高效分泌表达抗VEGF-Fab抗体片段的高产菌株及其构建方法 |
US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
AU2020243460A1 (en) | 2019-03-18 | 2021-10-07 | Bio-Rad Abd Serotec Gmbh | Protection of SpyTag-containing periplasmic fusion proteins from protease Tsp and ompT degradation |
CN114829578A (zh) * | 2019-08-05 | 2022-07-29 | 瓦克化学股份公司 | 用于在发酵方法中释放重组蛋白的细菌菌株 |
JPWO2021193566A1 (da) * | 2020-03-23 | 2021-09-30 | ||
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
SE545714C2 (en) * | 2021-09-24 | 2023-12-19 | Xbrane Biopharma Ab | Dna contructs for producing a pelb signal peptide |
CA3232722A1 (en) | 2021-09-24 | 2023-03-30 | Kiavash MIRZADEH | Dna constructs and host cells for expressing recombinant protein |
SE545715C2 (en) * | 2021-09-24 | 2023-12-19 | Xbrane Biopharma Ab | Dna contructs comprising tirs for producing recombinant proteins |
SE545694C2 (en) * | 2021-09-24 | 2023-12-05 | Xbrane Biopharma Ab | Dna construct comprising nucleotide sequences encoding amino acid sequences of certolizumab and pelb signal peptides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439523A (en) * | 1981-07-07 | 1984-03-27 | Phillips Petroleum Company | Production of single cell protein material |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DE3853745D1 (de) | 1987-01-30 | 1995-06-14 | Harvard College | Periplasmische protease-mutanten von escherichia coli. |
CA1341235C (en) | 1987-07-24 | 2001-05-22 | Randy R. Robinson | Modular assembly of antibody genes, antibodies prepared thereby and use |
US5508192A (en) | 1990-11-09 | 1996-04-16 | Board Of Regents, The University Of Texas System | Bacterial host strains for producing proteolytically sensitive polypeptides |
US20020037558A1 (en) | 1991-10-23 | 2002-03-28 | Kin-Ming Lo | E.coli produced immunoglobulin constructs |
US6251395B1 (en) * | 1993-12-23 | 2001-06-26 | W. Michael Gallatin | Methods of inhibiting inflammation at the site of a central nervous system injury with alphaD-specific antibodies |
FR2787810B1 (fr) | 1998-12-24 | 2002-10-31 | Inst Nat De La Rech Agronomique Inra | Bacteries a gram positif depourvues d'activite proteasique htra, et leurs utilisations |
-
2001
- 2001-12-07 NZ NZ526134A patent/NZ526134A/en not_active IP Right Cessation
- 2001-12-07 AU AU3957602A patent/AU3957602A/xx active Pending
- 2001-12-07 KR KR1020037007918A patent/KR100841486B1/ko active IP Right Grant
- 2001-12-07 WO PCT/US2001/047581 patent/WO2002048376A2/en active IP Right Grant
- 2001-12-07 PL PL366194A patent/PL205897B1/pl unknown
- 2001-12-07 RU RU2003121232/13A patent/RU2287574C2/ru active
- 2001-12-07 US US10/011,125 patent/US6828121B2/en not_active Expired - Lifetime
- 2001-12-07 EP EP01987349A patent/EP1341899B9/en not_active Expired - Lifetime
- 2001-12-07 AT AT01987349T patent/ATE318890T1/de active
- 2001-12-07 CN CNB018226590A patent/CN1233820C/zh not_active Expired - Lifetime
- 2001-12-07 DE DE60117601T patent/DE60117601T2/de not_active Expired - Lifetime
- 2001-12-07 CZ CZ2003-1523A patent/CZ304484B6/cs not_active IP Right Cessation
- 2001-12-07 MX MXPA03005271A patent/MXPA03005271A/es active IP Right Grant
- 2001-12-07 IL IL15611101A patent/IL156111A0/xx unknown
- 2001-12-07 AU AU2002239576A patent/AU2002239576B2/en not_active Expired
- 2001-12-07 HU HU0303892A patent/HU230065B1/hu unknown
- 2001-12-07 JP JP2002550091A patent/JP4056880B2/ja not_active Expired - Lifetime
- 2001-12-07 BR BR0116680-8A patent/BR0116680A/pt not_active Application Discontinuation
- 2001-12-07 ES ES01987349T patent/ES2259338T3/es not_active Expired - Lifetime
- 2001-12-07 CA CA002430249A patent/CA2430249A1/en not_active Abandoned
- 2001-12-07 DK DK01987349T patent/DK1341899T3/da active
-
2003
- 2003-05-26 IL IL156111A patent/IL156111A/en active IP Right Grant
- 2003-05-27 ZA ZA2003/04101A patent/ZA200304101B/en unknown
- 2003-06-13 NO NO20032694A patent/NO328987B1/no not_active IP Right Cessation
-
2004
- 2004-02-27 HK HK04101420A patent/HK1058686A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1341899T3 (da) | Bakterieværtsstammer | |
IE880558L (en) | Stable gene amplification in prokaryotic chromosomal dna | |
AU1278595A (en) | Non-toxic mucosal adjuvant | |
EP0994190A3 (en) | DNA conferring L-homoserine resistance to bacteria, and its use | |
AU2002314204A1 (en) | Process for the preparation of l-amino acids using strains of the enterobacteri acea family which contain an attenuated aspa gene | |
MXPA04005312A (es) | Polipeptidos que tienen actividad de proteasa y acidos nucleicos que los codifican. | |
WO2003023030A3 (en) | Aminopeptidase | |
WO2002031158A3 (en) | Feedback-resistant pyruvate carboxylase gene from corynebacterium | |
EP1546384A4 (en) | CONSTRUCTION OF THE BACILLUS LICHENIFORM T1 BRAIN AND FERMENTATION PRODUCT OF AN ENZYMRO-EXTRACTS | |
WO2006106435A3 (en) | Fusion protein comprising a hiv nef double mutant and its use therapy | |
WO2003087149A3 (en) | Bacillus licheniformis mutant host cell | |
AU2001281068A1 (en) | 2,5-dkg permeases | |
NO932811L (no) | Gjaervertstamme med N-glykosyleringsdefecter | |
WO2005045045A3 (en) | Recombinant microorganism | |
EP0085958A3 (en) | Method for producing l-phenylalanine by fermentation | |
JP2009038985A (ja) | 微生物及びこれを用いたタンパク質又ポリペプチドの製造方法 | |
WO2002031172A3 (en) | L-threonine producing e. coli strain | |
JP2009038985A5 (da) | ||
AU2857192A (en) | Gene coding for esterase and novel microorganism containing said gene | |
Vinci | Biochemical and genetic analysis of serine proteases of Streptomyces spp. | |
MD1541G2 (ro) | Mediu de cultură pentru acumularea biomasei de bifidobacterii | |
AU1430992A (en) | A process for producing chymosin | |
ES2188412A1 (es) | Preparacion de medios de cultivo agar y caldo tenacibaculum maritimum (agar tm y caldo tm) |